Emerg Infect Dis. 2022 Mar;28(3):684-692. doi: 10.3201/eid2803.211919.
We evaluated the effects of the coronavirus disease pandemic on diagnosis of and treatment for tuberculosis (TB) in Vietnam. We obtained quarterly notifications for TB and multidrug-resistant/rifampin-resistant (MDR/RR) TB from 2015-2020 and evaluated changes in monthly TB case notifications. We used an interrupted time series to assess the change in notifications and treatment outcomes. Overall, TB case notifications were 8% lower in 2020 than in 2019; MDR/RR TB notifications were 1% lower. TB case notifications decreased by 364 (95% CI -1,236 to 508) notifications per quarter and MDR/RR TB by 1 (95% CI -129 to 132) notification per quarter. The proportion of successful TB treatment outcomes decreased by 0.1% per quarter (95% CI -1.1% to 0.8%) in 2020 compared with previous years. Our study suggests that Vietnam was able to maintain its TB response in 2020, despite the pandemic.
我们评估了冠状病毒病大流行对越南结核病（TB）诊断和治疗的影响。我们获得了 2015-2020 年每季度的结核病和耐多药/利福平耐药（MDR/RR）结核病报告，并评估了每月结核病病例报告的变化。我们使用中断时间序列来评估通知和治疗结果的变化。总体而言，2020 年结核病病例报告比 2019 年减少 8%；耐多药/利福平耐药结核病报告减少 1%。结核病病例报告每季度减少 364 例（95%CI-1,236 至 508），耐多药/利福平耐药结核病报告每季度减少 1 例（95%CI-129 至 132）。与前几年相比，2020 年结核病治疗成功的比例每季度下降 0.1%（95%CI-1.1%至 0.8%）。我们的研究表明，尽管面临大流行，越南在 2020 年仍能够维持其结核病应对措施。
Zotero 插件
